Global Contrast Enhanced Ultrasound Market

Global Contrast Enhanced Ultrasound Market By Products (Equipment and Contrast Agent), By Types (Non-targeted and Targeted), By End-users (Hospitals, Clinics, Ambulatory Diagnostic Centers) and By Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021-2028

  • Report ID: HC-3203
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 212
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global contrast enhanced ultrasound market size was valued at USD 1.8 billion in 2020 and is expected to reach USD 2.5 billion at a compound annual growth rate (CAGR) of 4.2% from 2021 to 2028.

Global Contrast Enhanced Ultrasound Market summary

Factors such as introduction of cost-effective contrast agents, increasing demand for contrast imaging modes in ultrasound systems, and increasing ultrasound procedure volume for diagnosis of various diseases is anticipated to boost the market.

Contrast-enhanced ultrasound is defined as a technique that employs specialized imaging techniques and microbubble contrast agents. The technique is used to represent information regarding tissue perfusion and blood flow. CEUS is safe and is performed easily. The technique does not require ionizing radiation and has no risk of nephrotoxicity. Contrast enhanced ultrasound is abbreviated as CEUS. CEUS is more radiation-free, cost-efficient, and patient-friendly as compared to other technologies. These factors are expected to propel the market.

Contrast enhanced ultrasound is employed, due to the advantages offered such as early diagnosis of COVID-19-related pneumonia. Rapid rise in the number of ultrasonography procedures related to lungs is expected to boost the demand for this process, which in turn, is projected to drive the market. Moreover, the rising incidence of gastrointestinal and cardiovascular diseases is estimated to boost the demand for contrast enhanced ultrasound in the near future.

The emergence of COVID-19 has positively affected the market, owing to the involvement of contrast enhanced ultrasound in one of the preferred grading systems for assessment of lung deterioration in COVID-19 patients. CEUS aids in identification of lung damage during the asymptomatic phase of the COVID-19. Moreover, it is used as a bedside imaging tool to measure perfusion impairment in kidney, lung, and brain of pediatric COVID-19 patients. Considerable number of studies to detect the presence of microthrombi in COVID-19 patients is anticipated to increase the applications of CEUS and boost the usage of these devices in the near future.

Market Trends, Drivers, Restraints, and Opportunities:

  • Contrast enhanced ultrasound is used for imaging blood perfusion in organs, which drives the market.
  • Applications such as measurement of blood flow rate in the heart and other organs is anticipated to boost the market in the near future.
  • Supply chain disruptions and stringent protocols such as 50% capacity in facilities is projected to hamper the market growth.
  • Technological advancements and innovations are anticipated to create lucrative opportunities for the players in the market.

Scope of the report:

The report on the global contrast enhanced ultrasound market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Contrast Enhanced Ultrasound Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast

Base Year

2020

Historic Data

2018 & 2019

Forecast Period

2021–2028

Segmentation

By Products (Equipment and Contrast Agent), By Types (Non-targeted and Targeted), By End-users (Hospitals, Clinics, Ambulatory Diagnostic Centers)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

Key Players Covered in the Report

Siemens Healthcare Private Limited, Trivitron Healthcare, BK Medical Holding Company, Inc., General Electric Company, Bracco Diagnostic Inc., Bristol–Myers Squibb, and Sonus Pharmaceuticals

Contrast Enhanced Ultrasound Market Segment Insights:

High adoption of contrast agent to drive the market

Based on products, the market is bifurcated into equipment and contrast agent. The contrast agent segment is anticipated to grow at a rapid pace, owing to its adoption and rising demand. The introduction of advanced ultrasound units with transducer technology and nonlinear imaging techniques simplified the workflow of CEUS, thereby fueling the segmental share for equipment.

Non-Targeted Contrast Agent Segment Anticipated To Hold Substantial Share Of The Market

On the basis of types, the market is categorized into non-targeted and targeted. The ultrasound contrast agents used in contrast enhanced ultrasound are non-targeted. They are mostly employed to enhance diagnostic sensitivity and precision for determination of the blood volume and flow to help in differentiation between benign liver tumors and malignant. The non-targeted contrast agent segment is anticipated to hold the largest market share in 2020, owing to availability of commercial products of this type.

Global Contrast Enhanced Ultrasound Market types

Emergency Services Offered By Ambulatory Diagnostic Centers To Propel The Market

In terms of end-users, the market is fragmented into hospitals, clinics, and ambulatory diagnostic centers. The ambulatory diagnostic centers segment is expected to hold a large share of the market during the forecast period, owing to emergency services offered during COVID-19.

Global Contrast Enhanced Ultrasound Market end-users

R&D In Contrast Enhanced Ultrasound In North America To Drive The Market

Based on regions, the contrast enhanced ultrasound market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is expected to register substantial CAGR during the forecast period. Growth of the market in the region is attributed to research and development activities in contrast enhanced ultrasound in North America.

Global Contrast Enhanced Ultrasound Market region

Segments

Segments Covered in the Report:
By Products

  • Equipment
  • Contrast Agent

By Types

  • Non-targeted
  • Targeted

By End-Users

  • Hospitals
  • Clinics
  • Ambulatory Diagnostic Centers

By Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

By Key Players

  • Siemens Healthcare Private Limited
  • Trivitron Healthcare
  • BK Medical Holding Company, Inc.
  • General Electric Company
  • Bracco Diagnostic Inc.
  • Bristol–Myers Squibb
  • Sonus Pharmaceuticals

 

Competitive Landscape

• Key players in the market include Siemens Healthcare Private Limited, Trivitron Healthcare, BK Medical Holding Company, Inc., General Electric Company, Bracco Diagnostic Inc., Bristol–Myers Squibb, and Sonus Pharmaceuticals among others. These companies are considered as key players in the global contrast enhanced ultrasound market based on their revenue, product offerings, and supply chain management system.

• Players are adopting key strategies such as acquisition, collaborations, and geographical expansion to make use of potential opportunities in the global contrast enhanced ultrasound market.

Global Contrast Enhanced Ultrasound Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Contrast Enhanced Ultrasound Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Contrast Enhanced Ultrasound Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Contrast Enhanced Ultrasound Market - Supply Chain
  4.5. Global Contrast Enhanced Ultrasound Market Forecast
     4.5.1. Contrast Enhanced Ultrasound Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Contrast Enhanced Ultrasound Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Contrast Enhanced Ultrasound Market Absolute $ Opportunity
5. Global Contrast Enhanced Ultrasound Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
     5.3.1. Non-targeted
     5.3.2. Targeted
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Contrast Enhanced Ultrasound Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Contrast Enhanced Ultrasound Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
7. North America Contrast Enhanced Ultrasound Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Contrast Enhanced Ultrasound Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
     7.4.1. Non-targeted
     7.4.2. Targeted
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
8. Latin America Contrast Enhanced Ultrasound Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Contrast Enhanced Ultrasound Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
     8.4.1. Non-targeted
     8.4.2. Targeted
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
9. Europe Contrast Enhanced Ultrasound Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Contrast Enhanced Ultrasound Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
     9.4.1. Non-targeted
     9.4.2. Targeted
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
10. Asia Pacific Contrast Enhanced Ultrasound Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Contrast Enhanced Ultrasound Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
     10.4.1. Non-targeted
     10.4.2. Targeted
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
11. Middle East & Africa Contrast Enhanced Ultrasound Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Contrast Enhanced Ultrasound Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
     11.4.1. Non-targeted
     11.4.2. Targeted
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Contrast Enhanced Ultrasound Market: Market Share Analysis
  12.2. Contrast Enhanced Ultrasound Distributors and Customers
  12.3. Contrast Enhanced Ultrasound Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Siemens Healthcare Private Limited
     12.4.2. Trivitron Healthcare
     12.4.3. BK Medical Holding Company, Inc.
     12.4.4. General Electric Company
     12.4.5. Bracco Diagnostic Inc.
     12.4.6. Bristol–Myers Squibb
     12.4.7. Sonus Pharmaceuticals

Segments Covered in the Report:
By Products

  • Equipment
  • Contrast Agent

By Types

  • Non-targeted
  • Targeted

By End-Users

  • Hospitals
  • Clinics
  • Ambulatory Diagnostic Centers

By Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

By Key Players

  • Siemens Healthcare Private Limited
  • Trivitron Healthcare
  • BK Medical Holding Company, Inc.
  • General Electric Company
  • Bracco Diagnostic Inc.
  • Bristol–Myers Squibb
  • Sonus Pharmaceuticals

 

• Key players in the market include Siemens Healthcare Private Limited, Trivitron Healthcare, BK Medical Holding Company, Inc., General Electric Company, Bracco Diagnostic Inc., Bristol–Myers Squibb, and Sonus Pharmaceuticals among others. These companies are considered as key players in the global contrast enhanced ultrasound market based on their revenue, product offerings, and supply chain management system.

• Players are adopting key strategies such as acquisition, collaborations, and geographical expansion to make use of potential opportunities in the global contrast enhanced ultrasound market.

Global Contrast Enhanced Ultrasound Market keyplayers

Buy Report